Trial intelligence / Profile preview

Autologous ADMSCs for Sequelae of Severe Brain Injury

NCT01649700Phase 2Completed

Sponsor
National Yang Ming Chiao Tung University
Start
Oct 2011
Primary completion
May 2013
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in brain arteriovenous malformation (AVM), sponsored by National Yang Ming Chiao Tung University. Started Oct 2011; status: completed.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

brain arteriovenous malformation (AVM)

Beyond the preview

Go deeper on NCT01649700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01649700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call